期刊文献+

高强度聚焦超声治疗巨大子宫肌瘤的安全性及有效性研究 被引量:5

Study on safety and efficacy of high intensity focused ultrasound in treatment of giant uterine fibroids
下载PDF
导出
摘要 目的探讨高强度聚焦超声(HIFU)治疗巨大子宫肌瘤(GUR)的安全性及有效性,为临床合理治疗GUR提供依据。方法选取2011年6月至2015年5月在重庆医科大学附属第一医院海扶医院行HIFU治疗的GUR患者50例,治疗后第1天复查增强MRI测得并计算肌瘤消融率,治疗后6个月进行随访,比较治疗前、后瘤体大小的变化,随访临床症状改善情况;统计治疗后疼痛、下肢放射痛、阴道分泌物异常等不良反应情况,按国际介入放射治疗学会(SIR)标准评价治疗相关的不良反应;评估治疗的有效性及安全性。结果 50例患者共52个肌瘤均顺利接受HIFU消融治疗,治疗中均出现灰度改变,术后消融率为(77.8±14.9)%。治疗后6个月随访,肌瘤体积均小于治疗前,缩小率为(59.6±20.8)%,差异有统计学意义(P<0.05)。临床症状均有不同程度的改善。治疗后无严重并发症发生。结论 HIFU对GUR的治疗安全、有效,可以作为临床上GUR的治疗方案之一。 Objective To investigate the safety and effectiveness of high intensity focused ultrasound (HIFU) in the treatment of giant uterine fibroids(GUF) to provide evidence for its clinical rational treatment. Methods Totally 50 patients with GUF treated with HIFU in the Chongqing Haifu Hospital from June 2011 to May 2015 were selected. The enhanced MRI was reexamined on 1 d after treatment for measuring and calculating the fibroids ablation rate. Follow up was performed for 6 months after treatment. The change of tumor size was compared between before and after treatment, the improvement situation of clinical symptoms was followed up. The adverse reactions situation of pain after treatment, radiating pain of lower limbs and vaginal abnormal discharge was performed the statistics. The treatment related adverse reactions were evaluated according to the criteria of the International Society for Interventional Radiotherapy(SIR). The effectiveness and safety of treatment were evaluated. Results Total 52 GUF in 50 cases were smoothly received the HIFU ablation therapy ,the grey scale change was observed during treatment, the postoperative ablation rate was(77.8±14.9)%. The tumor volume was smaller than before treatment by 6-month follow up with the shrinkage rate of(59.6 ±20.8)% ,and the difference was statistically significant (P〈0.05) ,the clinical symptoms were improved in different degrees. No serious complications occurred after treatment. Conclusion HIFU is safe and effective for the treatment of GUF and can be used as one of treatment schemes in clinic.
出处 《现代医药卫生》 2016年第5期642-644,共3页 Journal of Modern Medicine & Health
基金 国家自然科学基金项目(81127901) 国家重点基础研究发展计划项目(2011CB707900)
关键词 平滑肌瘤/治疗 高强度聚焦超声 安全性 有效性 Leiomyoma/therapy High intensity focused ultrasound Security Validity
  • 相关文献

参考文献10

  • 1陈文直,唐良萏,杨武威,张彦,李静,夏文秀,周洁敏,祝宝让,赵纯全,令狐华,陈锦云,朱丽,邓勇斌,王智彪.超声消融治疗子宫肌瘤的安全性及有效性[J].中华妇产科杂志,2010,45(12):909-912. 被引量:86
  • 2Zhang L, Chen WZ,Liu YJ,et al. Feasibility of magnetic resonance imaging- guided high intensity focused ultrasound therapy for ablating uterinefibroids in patients with bowel lies anterior to uterus[J]. Eur J Radio1,2010,73 (2) : 396-403.
  • 3宦坚,张博,张伟,徐亮,周洁瑕,龚建平.巨大浆膜下子宫肌瘤的CT诊断及鉴别诊断[J].实用放射学杂志,2010,26(9):1308-1311. 被引量:13
  • 4Copelan A, Hartman J, Chehab M. High-intensity focused ultrasound: current status for image-guided therapy[J]. Semin Intervent Radiol, 2015, 32(4) :398-415.
  • 5LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRI- guided focused ultrasound treatment:report of 80 patients[J]. A JR Am J Roentgenol, 2010,194 ( 1 ) : 274-280.
  • 6Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease- specific symptom and health-related quality of life questionnaire for leio- myomata[J]. Obstet Gynecol, 2002,99 (2) : 290-300.
  • 7Smeets A J, Nijenhuis RJ,van Rooij WJ, et al. Uterine artery embolization in patients with a large fibroid burden :long-term clinical and MR follow- up[J]. Cardiovasc Intervent Radio1,2010,33 (5) : 943-948.
  • 8曾飚,周敏,华媛媛,胡建国,钟玲,熊正爱.高强度聚焦超声治疗子宫肌瘤的安全性分析[J].重庆医学,2013,42(4):370-372. 被引量:32
  • 9杨武威,祝宝让,李静,夏文秀,刘滢,盖绿华,周洁敏,孙继芳.超声消融治疗子宫肌瘤的近期并发症及其影响因素分析[J].中华妇产科杂志,2010,45(12):913-916. 被引量:55
  • 10邹敏,邓勇斌,王智亮,熊郁,陈骊,吴灿.高强度聚焦超声消融治疗子宫肌瘤后妊娠结局分析[J].中国超声医学杂志,2014,30(3):254-258. 被引量:40

二级参考文献52

  • 1高强度聚焦超声肿瘤治疗系统临床应用指南(试行)[J].中华医学杂志,2005,85(12):796-797. 被引量:57
  • 2杜铁桥,董杰,许全英,安海琴,桑春玉.输卵管卵巢脓肿的CT诊断价值[J].中华放射学杂志,2006,40(3):285-287. 被引量:35
  • 3王智彪.聚焦超声治疗技术在妇科领域的研究与应用[J].中华妇产科杂志,2006,41(9):638-640. 被引量:79
  • 4Payson M,Leppert P,Segars J.Epidemiology of myomas[J].Obstet Gynecol Clin North Am,2006,33(1):1-11.
  • 5Vitiello D,McCarthy S.Diagnostic imaging of myomas[J].Obstet Gynecol Clin North Am,2006,33(1):85-95.
  • 6Smith AK,Coakley FV,Jackon R,et al.CT and MRI of retroperitoneal edema associated with large uterine leiomyomas[J].J Comput Assist Tomogr,2002,26(3):459-461.
  • 7Miyake H,Hori Y,Dono S,et al.Low attenuation intratumoral matrix:CT and pathologic correlation[J].JCAT,2000,24 (5):761-772.
  • 8Reynolds A.Diagnosis and management of uterine fibroids[J].Radiol Technol,2007,79(2):157-178.
  • 9Toon C,McGahan S,Henderson P,et al.Myxoid symplastic leimyoma of the uterus[J].Pathology,2006,38(3):275-277.
  • 10Casillas J,Josepb RC,Guerra JJ.CT appearance of uterine leiomyomas[J].RadioGraphics,1990,10(6):999-1007.

共引文献183

同被引文献27

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部